GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
2,753
Funds Holding Change
+103
Funds Holding Growth
+4%
Value
$462B
Holding in Top 10
408
Top 10 Change
-136
Top 10 Growth
-25%
Value Growth
-9%
New
265
Increased
1,045
Reduced
1,283
Closed
108
Capital Inflow
$21B
Capital Outflow
$25B
Net Capital Flow
-$4.04B
Capital Flow Change
-$3.46B
Calls
$7.35B
Puts
$8.21B
Net Calls
-$860M
Put/Call Ratio
1.12